Thomas John
SEC CIK 1939103 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| GNLX | GENELUX Corp | Dir | 501.2K | — | $454.6K | 14 | 2023-01-30 | 2026-06-16 |
Most active insiders at GNLX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Zindrick Thomas | Pres, CEO | — | $117.7K |
| 2 | Thomas John | Dir | — | $108.8K |
| 3 | Smither John W | Dir | — | $34.9K |
| 4 | Cappello Joseph | Chief Technical Off | — | $34.0K |
| 5 | Yu Yong | SVP, Clinical Development | — | $32.6K |
| 6 | Smalling Ralph | Head of Regulatory | — | $2,804 |
| 7 | Pulisic Matthew | CFO | — | — |
| 8 | Mirabelli Mary | Dir | — | — |
| 9 | Groen Eric | GC | — | — |
| 10 | Tyree James L | Dir | — | — |
Transactions 14
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-18 19:05 | 2026-06-16 | GNLX | GENELUX Corp | Thomas John | Dir | A - Grant | $0.00 | +28.4K | 501.2K | +6% | $0 |
| T | 2026-06-02 20:35 | 2026-06-01 | GNLX | GENELUX Corp | Thomas John | Dir | S - Sale | $2.98 | -10.0K | 472.8K | -2% | -$29.8K |
| 2026-03-03 | 2026-03-02 | GNLX | GENELUX Corp | Thomas John | Dir | S - Sale | $2.90 | -10.0K | 482.8K | -2% | -$29.0K | |
| 2025-12-02 | 2025-12-01 | GNLX | GENELUX Corp | Thomas John | Dir | S - Sale | $5.00 | -10.0K | 492.8K | -2% | -$50.0K | |
| D | 2025-08-29 | 2025-08-27 | GNLX | GENELUX Corp | Thomas John | Dir | A - Grant | $0.00 | +22.3K | 502.8K | +5% | $0 |
| 2025-06-24 | 2025-06-06 | GNLX | GENELUX Corp | Thomas John | Dir | G - Gift | $0.00 | -25.0K | 480.5K | -5% | $0 | |
| D | 2024-08-05 | 2024-08-01 | GNLX | GENELUX Corp | Thomas John | Dir | A - Grant | $0.00 | +39.5K | 505.5K | +8% | $0 |
| D | 2024-06-07 | 2024-05-29 | GNLX | GENELUX Corp | Thomas John | Dir | P - Purchase | — | +2,500 | 466.0K | +0.5% | — |
| M | 2023-12-14 | 2023-12-13 | GNLX | GENELUX Corp | Thomas John | Dir | S - Sale | $13.38 | -9,000 | 465.4K | -2% | -$120.4K |
| M | 2023-10-16 | 2023-10-16 | GNLX | GENELUX Corp | Thomas John | Dir | S - Sale | $20.71 | -3,333 | 473.3K | -0.7% | -$69.0K |
| M | 2023-09-18 | 2023-09-15+ | GNLX | GENELUX Corp | Thomas John | Dir | S - Sale | $23.45 | -6,667 | 479.1K | -1% | -$156.3K |
| D | 2023-09-13 | 2023-09-11 | GNLX | GENELUX Corp | Thomas John | Dir | A - Grant | $0.00 | +3,460 | 482.5K | +0.7% | $0 |
| 2023-05-02 | 2023-02-17 | GNLX | GENELUX Corp | Thomas John | Dir | A - Grant | $0.00 | +9,000 | 479.0K | +2% | $0 | |
| D | 2023-01-30 | 2023-01-30 | GNLX | GENELUX Corp | Thomas John | Dir | C - Cnv Deriv | — | +470.0K | 470.0K | New | — |
Purchase Sale Sale after option exercise All abbreviations